𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support

✍ Scribed by William P. Peters; Ann Stuart; Mary Klotman; Colleen Gilbert; Roy B. Jones; Elizabeth J. Shpall; Jon Gockerman; Robert C. Bast; Joseph O. Moore

Publisher
Springer
Year
1989
Tongue
English
Weight
691 KB
Volume
23
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

High-dose melphalan and autologous bone
High-dose melphalan and autologous bone marrow transplant for relapsed acute leukaemia
✍ Dominique Maraninchi; Manuel Abecasis; Jean-Albert Gastaut; GΓ©rard Sebahoun; Jea πŸ“‚ Article πŸ“… 1983 πŸ› Springer 🌐 English βš– 246 KB

Seven patients with relapsed acute leukaemia were treated with high-dose melphalan (HDM) followed by the infusion of autologous cryopreserved remission marrow. Toxicy was minimal and all seven patients had a complete response. Four patients are still in unmaintained remission at 14, 13, 10, and 3 mo

Late intensification with high-dose melp
Late intensification with high-dose melphalan and autologous bone marrow support in breast cancer patients responding to conventional chemotherapy
✍ Mark D. Vincent; Trevor J. Powles; R. Charles Coombes; T. J. McElwain πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 557 KB

Fifteen patients with advanced breast cancer who had achieved either a good partial or a complete response to conventional chemotherapy were selected to receive intensification treatment with high-dose melphalan 140-200 mg/m2 (HDM). All patients received autologous bone marrow rescue. All patients e